Duquesne Family Office’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $183M | Sell |
|
|||||
|
2025
Q3 | $335M | Buy |
|
|||||
|
2025
Q2 | $268M | Buy |
|
|||||
|
2025
Q1 | $229M | Buy |
|
|||||
|
2024
Q4 | $198M | Buy |
|
|||||
|
2024
Q3 | $25.7M | Buy |
|
|||||
|
2015
Q2 | – | Sell |
|
|||||
|
2015
Q1 | $49.2M | Buy |
|
|||||
|
2014
Q3 | – | Sell |
|
|||||
|
2014
Q2 | $65.1M | Hold |
|
|||||
|
2014
Q1 | $65.6M | Hold |
|
|||||
|
2013
Q4 | $49.7M | Buy |
|